DUBLIN, Aug. 18, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/7dtjb9/tumor_ablation) has announced the addition of the "Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound), Mode of treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecasts to 2020" report to their offering.
On the basis of technology, the global tumor ablation market is segmented into radiofrequency ablation, microwave ablation, cryoablation, and other technologies (including irreversible electroporation, radioiodine, HIFU, and laser ablation). The radiofrequency ablation technology segment accounted for the largest share of the global market in 2014.
However, the microwave ablation technology segment is expected to grow at the highest CAGR in the next five years, owing to factors such as recently proven clinical efficiency in cancer treatments, growing adoption of microwave tumor ablation among healthcare professionals to treat various cancers, increasing private funding for novel product developments, advantages offered by microwave techniques over other tumor ablation techniques, ongoing technological advancements in the field of microwave ablation, and expansion in the application horizon of microwave ablation techniques for various cancers.
On the basis of application, the global tumor ablation market is classified into liver cancer, lung cancer, kidney cancer, bone metastasis, and other applications (includes cancers of prostate, breast, colorectal, neuroendocrine, head, neck, and lumbar vertebrae). The liver cancer application segment accounted for the largest share of the global market in 2014.
However, the lung cancer application segment is expected to grow at the highest CAGR in the next five years, owing to growing private investment to develop and commercialize innovative lung cancer ablation products, ongoing technological advancements in the field of microwave-based lung cancer ablation technique, and large patient population of lung cancer patients across mature and emerging markets.
Geography, the tumor ablation market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2014, the global market was dominated by North America owing to factors such as early introduction and high adoption rate of tumor ablation products in the region, significant trend of replacing older technologies with advanced and innovative therapeutic techniques (such as microwave ablation and cryoablation), and increasing private/public funding to develop and commercialize novel tumor ablation products.
However, the Asia-Pacific market is expected to grow at the highest CAGR in the forecast period due to factors such as large population base paired with high prevalence of various cancers (such as liver, lung, and kidney) in the region, ongoing government initiatives for development and modernization of healthcare infrastructure, increasing adoption owing to continuously decreasing device price associated with products, and rising trends related to localized manufacturing due to growing focus of global giants in the APAC market.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Tumor Ablation Market, By Technology
8 Tumor Ablation Market, By Mode of Treatment
9 Tumor Ablation Market, By Application
10 Tumor Ablation Market, By Region
11 Competitive Landscape
12 Company Profiles
- Angiodynamics, Inc.
- Boston Scientific Corporation
- EDAP TMS S.A.
- Galil Medical, Inc.
- Healthtronics, Inc.
- Medtronic, PLC.
- Mermaid Medical A/S
- Misonix, Inc.
- Neuwave Medical, Inc.
- Sonacare Medical, LLC
For more information visit
Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets